RESUMEN
Introduction: Beta thalassemia and hemoglobin (HbE)-related hemoglobinopathies are common public health problems in developing countries. High-performance liquid chromatography (HPLC) is currently the diagnostic test of choice for carrier detection, but it is costly. Hence, some initial screening and complementary tests are required, which can be affordable. Aims: To find out the distribution of different red blood cell (RBC) indices in beta thalassemia trait (BTT) and HbE-related hemoglobinopathies and to determine their significance as screening tests to distinguish between these hemoglobinopathies. Study Settings and Design: This observational cross-sectional study has been carried out at an NABL (National Accreditation Board for Testing and Calibration Laboratories)-accredited Laboratory of Eastern India with approval from the concerned Institutional Ethics Committee from January 2021 to March 2021. Methods and Material: : HPLC tests and complete hemograms were performed on 2247 ethylenediaminetetraacetic acid anti-coagulated blood samples over 3 months. Patients <1 year of age or having a history of blood transfusion within the past 06 months were excluded. Statistical Analysis: : One-way analysis of variance along with Bonferroni post-hoc test was performed to find out significant differences of means of mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), hemoglobin%, red blood cell (RBC) count, and red cell distribution width (RDW-CV) among concerned hemoglobinopathies. Results: The results show a significant difference of total RBC count, RDW, MCV, MCH, and MCHC between BTT and E-trait. No significant difference of mean was found between HbE homozygous and E-beta. E-trait differs from both HbE homozygous and E-beta significantly in three parameters, namely, RDW, MCV and MCH. A value of MCV at ≤73.8 fl and MCH at ≤21.9 pg may be a clue of diagnosis for BTT rather than E-trait with >90% sensitivity and >80% specificity. Conclusion: RBC indices vary significantly between BTT and other HbE-related hemoglobinopathies. They can specially be utilized to differentiate BTT and E-trait as supportive tests in addition to the gold standard test of HPLC.
Asunto(s)
Hemoglobinopatías , Talasemia beta , Humanos , Lactante , Índices de Eritrocitos , Estudios Transversales , Hemoglobinopatías/diagnóstico , Hemoglobinas , India , EritrocitosRESUMEN
OBJECTIVES: The present study aimed to evaluate the role of hyperlipidemia in increased formation of advanced lipoxidation end products (ALEs) and to evaluate whether there is any relationship between ALEs generation and erythrocyte glucose-6-phosphate dehydrogenase (G6PD) activity in cases of mild nonproliferative diabetic retinopathy (MNPDR). METHODS: In this study, we enrolled 100 patients with type 2 diabetes and MNPDR, 100 subjects with type 2 diabetes but without retinopathy (DNR) and 90 normal individuals without diabetes as healthy controls (HCs). Erythrocyte nicotinamide dinucleotide phosphate (NADPH), G6PD activity, serum total cholesterol, low- and high-density lipoprotein (LDL, HDL) and triglyceride levels were determined by photometric assay. Serum malondialdehyde (MDA) protein adduct and hexanoyl-lysine (HEL) were measured by an enzyme-linked immunosorbent assay (ELISA). RESULTS: A robust linear relationship was observed between MDA protein adduct and LDL or cholesterol or triglyceride levels, and HEL and LDL or cholesterol or triglyceride levels in subjects with MNPDR (p=0.0001). A significant inverse association was observed between erythrocyte G6PD activity and serum MDA protein adductor HEL levels in subjects with MNPDR (p=0.0001). CONCLUSIONS: Hyperlipidemia is an important factor that is associated with increased ALEs formation in persons with MNPDR. Increased ALEs generation was associated with decreased G6PD activity and low NADPH levels in cases of MNPDR, suggesting their detrimental role in the occurrence of early NPDR.
Asunto(s)
Productos Avanzados de Oxidación de Proteínas/sangre , Diabetes Mellitus Tipo 2/sangre , Retinopatía Diabética/sangre , Eritrocitos/metabolismo , Glucosafosfato Deshidrogenasa/sangre , Hiperlipidemias/sangre , Adulto , Biomarcadores/sangre , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/epidemiología , Retinopatía Diabética/diagnóstico , Retinopatía Diabética/epidemiología , Femenino , Humanos , Hiperlipidemias/diagnóstico , Hiperlipidemias/epidemiología , Masculino , Persona de Mediana Edad , Oxidación-ReducciónAsunto(s)
Recolección de Muestras de Sangre/normas , Geles/química , Paraproteinemias/diagnóstico , Anciano , Anciano de 80 o más Años , Recolección de Muestras de Sangre/instrumentación , Errores Diagnósticos , Femenino , Humanos , Laboratorios , Masculino , Persona de Mediana Edad , Mieloma Múltiple/patología , Albúmina Sérica/análisis , Seroglobulinas/análisisRESUMEN
A 50 year old male was admitted in our hospital with anemia and impaired renal function. He was subsequently found to have extremely elevated serum phosphate level (24 mg/dL, reference interval: 2.5-4.5 mg/dL) with normal serum calcium when assayed on a Beckman Coulter AU 480(®) analyser. Clinico-biochemical discrepancy led to the suspicion of spurious hyperphosphatemia. Serum total protein was grossly elevated with gross reversal of albumin to globulin ratio. Serum electrophoresis revealed a large M band and was confirmed as Ig G-Kappa type on immunofixation. Subsequently a bone marrow aspiration biopsy confirmed the diagnosis of multiple myeloma. The patient serum was then reassayed for phosphate on a Vitros(®) 250 Dry Chemistry platform and the result was within normal reference interval. Paraproteinemias are a common cause of analytical interference in clinical biochemistry laboratories and as multilayered film technology platforms like Vitros(®) assay most routine analytes on a protein free filtrate they are unaffected by paraprotein interference. Clinically discordant patient results should always be interpreted keeping such interferences in mind.
RESUMEN
Heavy metal toxicity is often caused by occupational exposure. Chronic cadmium toxicity is a significant health concern among workers engaged in zinc smelting, battery production and silver jewellery industries, particularly in developing countries. We report the case of a 48-year-old man who presented with severe osteoporosis, impaired renal function and acquired Fanconi syndrome. He was finally diagnosed with chronic cadmium toxicity resulting from long-term occupational exposure. Cadmium has a long biological half-life and there is no effective treatment for people who are exposed to it. Therefore, an early diagnosis and prevention of further exposure are important.
Asunto(s)
Intoxicación por Cadmio/diagnóstico , Síndrome de Fanconi/diagnóstico , Exposición Profesional/efectos adversos , Osteoporosis/diagnóstico , Insuficiencia Renal Crónica/diagnóstico , Huesos/metabolismo , Huesos/patología , Cadmio/sangre , Cadmio/orina , Intoxicación por Cadmio/sangre , Intoxicación por Cadmio/orina , Síndrome de Fanconi/sangre , Síndrome de Fanconi/inducido químicamente , Síndrome de Fanconi/orina , Humanos , Riñón/metabolismo , Riñón/patología , Masculino , Persona de Mediana Edad , Osteoporosis/sangre , Osteoporosis/inducido químicamente , Osteoporosis/orina , Insuficiencia Renal Crónica/sangre , Insuficiencia Renal Crónica/inducido químicamente , Insuficiencia Renal Crónica/orinaAsunto(s)
Confusión/sangre , Hiponatremia/sangre , Mielinólisis Pontino Central/sangre , Solución Salina Hipertónica/efectos adversos , Sodio/sangre , Antihipertensivos/efectos adversos , Confusión/inducido químicamente , Confusión/diagnóstico , Confusión/fisiopatología , Resultado Fatal , Humanos , Hidroclorotiazida/efectos adversos , Hiponatremia/inducido químicamente , Hiponatremia/diagnóstico , Hiponatremia/fisiopatología , Masculino , Persona de Mediana Edad , Mielinólisis Pontino Central/inducido químicamente , Mielinólisis Pontino Central/diagnóstico , Mielinólisis Pontino Central/patología , Solución Salina Hipertónica/administración & dosificaciónRESUMEN
Urinary iodine levels in children (6-12 years) living in three rural blocks and in the municipal urban area of Bardhaman District, West Bengal, were analyzed to compare the status of recent iodine nutrition in the rural and urban population of the district. Goiter, indicating previous iodine status, was simultaneously estimated. Iodine levels in salt samples, that provide insight into the usage of iodized salt, were estimated. Data indicated that 56.6% of urban children and 51.1% of rural children were biochemically iodine repleted and had urinary iodine excretion (UIE) levels > or = 10microg/dl. Urban children (29.4%) and rural children (37.1%) were found to have goiter. Eighty percent and 50% of the rural and urban salt samples, respectively, were found to have iodine levels below 10 ppm; with significant urban-rural differences. The results indicate that iodine repletion in the surveyed area needs continuous surveillance of the proper distribution and use of iodized salt.